Inactive Instrument

501 ACQU

Equities

FVAM

US33836P1057

5:01 ACQUISITION CORP. Change in Directors or Principal Officers (form 8-K)

April 25, 2022 at 09:02 am EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 22, 2022, Dr. Martin Mackay, Ph.D., a member of the board of directors (the "Board") of 5:01 Acquisition Corp. (the "Company"), notified the Board of his decision to resign from the Board, effective immediately. Dr. Mackay was a member of the Audit Committee. In connection with and effective immediately following Dr. Mackay's resignation, the Board appointed Samantha Singer, currently serving as an independent director of the Company, to the Audit Committee.

Dr. Mackay's decision to resign is not based on any disagreement with the Company or its management. He has served on the Company's Board since October 2020.

Latest news about 501 ACQU

5:01 Acquisition Corp.(NasdaqCM:FVAM) dropped from NASDAQ Composite Index	22-10-25	CI
5:01 Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
5:01 Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
5:01 Acquisition Corp. Announces Resignation of Martin Mackay as A Member of the Board of Directors	22-04-25	CI
5:01 Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-09	CI
5:01 Acquisition Corp. Auditor Raises 'Going Concern' Doubt	22-03-08	CI
5:01 Acquisition Corp. Auditor Raises 'Going Concern' Doubt	21-12-08	CI
5:01 Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
5:01 Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-11	CI
5:01 Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-07	CI
Certain Class B Common Stock of 5:01 Acquisition Corp. are subject to a Lock-Up Agreement Ending on 12-APR-2021.	21-04-11	CI
5:01 Acquisition Corp. Reports Earnings Results for the Period from August 31, 2020 to December 31, 2020	21-03-17	CI
5:01 Acquisition Corp. announced that it has received $3.6 million in funding from 5:01 Acquisition LLC	20-10-15	CI
5:01 Acquisition Corp. has completed an IPO in the amount of $80 million.	20-10-13	CI
5:01 Acquisition Corp. has filed an IPO in the amount of $80 million.	20-09-25	CI
5:01 Acquisition Corp. announced that it expects to receive $3.6 million in funding from 5:01 Acquisition LLC	20-09-09	CI

Chart 501 ACQU

Duration

Period

More charts

Company Profile

5:01 Acquisition Corp is a blank check company. The Company is created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. The Company focuses on early stage North American or European companies in the biotechnology sector of the healthcare industry. The Company has no operations and has not generated revenues.

Sector

More about the company